Legend Biotech Corporation (LEGN)
LEGN price $18.60 -0.41 -2.16%
- Ticker
- LEGN
- Price
- $18.60
- Change
- -0.41 -2.16%
- Market cap
- $3.44B
- P/E
- -38.02
- Forward P/E
- 34.36
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 62
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM)…